Subthalamic nucleus but not entopeduncular nucleus deep brain stimulation enhances neurogenesis in the SVZ-olfactory bulb system of Parkinsonian rats

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Mareike Fauser - , Universitätsmedizin Rostock (Autor:in)
  • Jan Philipp Payonk - , Universität Rostock (Autor:in)
  • Hanna Weber - , Universitätsmedizin Rostock (Autor:in)
  • Meike Statz - , Universitätsmedizin Rostock (Autor:in)
  • Christine Winter - , Charité – Universitätsmedizin Berlin (Autor:in)
  • Ravit Hadar - , Charité – Universitätsmedizin Berlin (Autor:in)
  • Revathi Appali - , Universität Rostock (Autor:in)
  • Ursula van Rienen - , Universität Rostock (Autor:in)
  • Moritz D Brandt - , Klinik und Poliklinik für Neurologie, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) - Standort Dresden (Autor:in)
  • Alexander Storch - , Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) - Standort Rostock/Greifswald (Autor:in)

Abstract

INTRODUCTION: Deep brain stimulation (DBS) is a highly effective treatment option in Parkinson's disease. However, the underlying mechanisms of action, particularly effects on neuronal plasticity, remain enigmatic. Adult neurogenesis in the subventricular zone-olfactory bulb (SVZ-OB) axis and in the dentate gyrus (DG) has been linked to various non-motor symptoms in PD, e.g., memory deficits and olfactory dysfunction. Since DBS affects several of these non-motor symptoms, we analyzed the effects of DBS in the subthalamic nucleus (STN) and the entopeduncular nucleus (EPN) on neurogenesis in 6-hydroxydopamine (6-OHDA)-lesioned hemiparkinsonian rats.

METHODS: In our study, we applied five weeks of continuous bilateral STN-DBS or EPN-DBS in 6-OHDA-lesioned rats with stable dopaminergic deficits compared to 6-OHDA-lesioned rats with corresponding sham stimulation. We injected two thymidine analogs to quantify newborn neurons early after DBS onset and three weeks later. Immunohistochemistry identified newborn cells co-labeled with NeuN, TH and GABA within the OB and DG. As a putative mechanism, we simulated the electric field distribution depending on the stimulation site to analyze direct electric effects on neural stem cell proliferation.

RESULTS: STN-DBS persistently increased the number of newborn dopaminergic and GABAergic neurons in the OB but not in the DG, while EPN-DBS does not impact neurogenesis. These effects do not seem to be mediated via direct electric stimulation of neural stem/progenitor cells within the neurogenic niches.

DISCUSSION: Our data support target-specific effects of STN-DBS on adult neurogenesis, a putative modulator of non-motor symptoms in Parkinson's disease.

Details

OriginalspracheEnglisch
Aufsatznummer1396780
FachzeitschriftFrontiers in cellular neuroscience
Jahrgang18
PublikationsstatusVeröffentlicht - 2024
Peer-Review-StatusJa

Externe IDs

PubMedCentral PMC11091264
Scopus 85193007539

Schlagworte

Bibliotheksschlagworte